The Lattanzio infection trial, running through October 30, 2026, tests whether infection claims fare like the $40 million fracture verdict — or face a harder ro...
The FDA classified Medtronic's Bravo reflux-test capsule recall as Class I after 184 serious injuries were reported. Here are the affected devices, the two diff...
A New Jersey bankruptcy judge approved a $535 million talc settlement for defunct supplier Whittaker Clark & Daniels, overruling claimants who called it too sma...
TikTok and YouTube settled with both plaintiffs and Meta settled with SJ only, leaving 18-year-old KDB's claims against Meta and Snap for a Los Angeles jury — w...
Judge Rosenstengel ordered attorney R. Allen Smith to disclose his cases' funding and bring each of his roughly 700 opt-out clients before her, after only 49 of...
Alexis Inman's son Daniel died after developing NEC in a NICU where he was fed Enfamil Premature formula. A unanimous Chicago jury found the formula did not cau...
While the first bellwether trial against L'Oréal USA is set for September 7, 2027, a second group of manufacturers — Wella, John Paul Mitchell, Bronner Bros., a...
Jose Luis Martir Navarro developed fatal silicosis after 13 years fabricating countertops. The $33 million verdict, the fifth plaintiff win in six trials, holds...
Greg Lassiter changed motorcycle brakes as a teenager in the 1970s. Decades later, a unanimous Georgia jury held Honda and Yamaha 100 percent liable for his mes...
The Flo administrator flagged 21.7 million claims and left at least 461,766 standing. The October 22 filing raised the estimated payment for survivors — and set...
Dupixent's federal litigation reached its first hearing in October 2026. The 'cancer hides behind eczema' argument is now on the court's agenda — but no trial d...